| 证券代码：300501 | 证券简称：海顺新材 | 公告编号：2025-059 | | --- | --- | --- | | 债券代码：123183 | 债券简称：海顺转债 | | 上海海顺新型药用包装材料股份有限公司 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示： 1、"海顺转债"（债券代码：123183）的转股期限为 2023 年 1 0 月 9 日至 2029 年 3 月 22 日，最新的转股价格为人民币 17.48 元/ 股。 2、2025 年第二季度，共有 20 张"海顺转债"完成转股，合计 转成 112 股"海顺新材"（股票代码：300501）股票。 3、截止 2025 年第二季度末，公司剩余可转换公司债券为 6,328, 836 张，剩余票面总金额为 632,883,600 元人民币。 关于2025年第二季度可转换公司债券转股情况的公告 根据《深圳证券交易所创业板股票上市规则》和《深圳证券交易 所上市公司自律监管指引第 15 号——可转换公司债券》的有关规定， 上海海顺新型药用包装材料股份有限公司（以下简称"公司"）现将 202 ...

Group 1 - Hengbang Co., Ltd. plans to establish a joint venture with Huasheng Development with a registered capital of 10 million yuan, where Hengbang will contribute 8 million yuan (80%) and Huasheng will contribute 2 million yuan (20%) [1] - Hunan Gold's subsidiary Anhua Zhazi Creek Smelting Plant will undergo temporary maintenance starting from the end of June 2025, expected to last no more than 30 days [2] - Defu Technology's subsidiary signed supply agreements for lithium battery copper foil products with two leading global companies, with contract durations of 3 years and 5 years respectively [3] Group 2 - Binjiang Group won the rights to two residential land parcels for a total price of 4.368 billion yuan [5] - Zhong'an Technology announced the resignation of its executive vice president and board secretary due to personal reasons [7] - Changqing Technology's project for special polymer materials and electronic materials has officially commenced production, adding a capacity of 120,500 tons per year [10] Group 3 - Gansu Energy received approval from the China Securities Regulatory Commission to publicly issue bonds totaling up to 2 billion yuan [10] - Shuoshi Biology obtained a medical device registration certificate for an in vitro diagnostic reagent, valid until June 2030 [12] - Yawen Co., Ltd. plans to issue shares to specific investors, with the application accepted by the Shenzhen Stock Exchange [13] Group 4 - Guoyao Modern's subsidiary received approval for the listing of a raw material drug, which is a selective anticholinergic agent [16] - Inner Mongolia First Machinery's subsidiary signed a railway freight car procurement contract worth 130 million yuan [18] - Xining Special Steel plans to raise up to 1 billion yuan through a private placement to its controlling shareholder [39] Group 5 - Huadong Medicine's subsidiary received approval for a clinical trial of a new injectable drug targeting advanced solid tumors [29] - Warner Pharmaceutical's compound potassium hydrogen phosphate injection passed the consistency evaluation for generic drugs [30] - North Special Technology plans to raise up to 300 million yuan through a private placement for a production base project in Thailand [30] Group 6 - Xiangyang Technology is the first candidate for a 533 million yuan Airbus project [45] - Haishun New Materials intends to acquire 100% of Guangdong Zhengyi Packaging [46] - Jida Zhengyuan's shareholder plans to reduce their stake by up to 0.73% due to personal financial needs [47]

Core Viewpoint - The company HaiShun New Materials is planning to acquire 100% equity of Guangdong Zhengyi Packaging Co., Ltd. for an initial transaction price of 94.87 million yuan, aiming to enhance its competitive edge and market share in the packaging industry [1][2]. Group 1: Acquisition Details - The acquisition involves Zhengyi Packaging, established in 1998, which specializes in the research, production, and sales of packaging films with applications in food, beverages, pharmaceuticals, and cosmetics [1]. - Zhengyi Packaging has production lines for aluminum oxide films, vacuum aluminum films, and coated films, with an annual production capacity exceeding 20,000 tons [1]. - As of the end of 2024, Zhengyi Packaging's total assets are reported at 80.63 million yuan, net assets at 46.84 million yuan, with projected revenue of 112 million yuan and net profit of 10.13 million yuan for the same year [1]. Group 2: Strategic Importance - The acquisition is seen as a strategic move to integrate resources and enhance the company's overall competitiveness and market presence [2]. - Post-acquisition, Zhengyi Packaging will become a wholly-owned subsidiary, allowing for synergy in products, technology, and market areas [2]. - The company plans to establish a technology-sharing mechanism and strengthen its technological barriers through patent licensing and cooperation [2]. Group 3: Financial Performance - In 2024, the company reported a revenue of 1.143 billion yuan, a year-on-year increase of 11.92%, while net profit decreased by 12.70% to 74.59 million yuan [3]. - For the first quarter of 2025, revenue reached 286 million yuan, up 10.46% year-on-year, but net profit fell by 24.99% to 17.27 million yuan [3]. Group 4: Product Development and Market Trends - The company has established a high-performance medical film division focusing on products like ostomy pouch films and high-end infusion films, and an electronic materials division targeting UV adhesive tapes and PI high-temperature adhesive tapes [3]. - The company is also focusing on solid-state batteries, with aluminum-plastic films identified as the most suitable packaging material, anticipating significant market growth as the industry matures [4]. - The company is currently working on client certifications and has improved its thermal process technology for aluminum-plastic films, expecting substantial sales growth in 2024 [4].

Suspension - Songyang Resources is planning a change in control, leading to a suspension of its stock [1] Private Placement and Mergers - Beite Technology plans to raise no more than 300 million yuan for the construction of a screw production base in Thailand [2] - Xining Special Steel intends to raise no more than 1 billion yuan to supplement its working capital [3] - Haishun New Materials is planning to acquire 100% equity of Guangdong Zhengyi Packaging Co., Ltd. through cash payment [3] Share Buybacks and Transfers - Shaanxi Jinye's actual controller proposed a buyback of 40 million to 70 million yuan [4] - Huate Dain's shareholder Guo Weisong plans to continue increasing his stake by 1.85% to 3.70% [5] - Zhongying Technology's shareholder is inquiring about a share transfer at a price of 31 yuan per share [6] - Rebecca's controlling shareholder is transferring 6.18% of shares through an agreement [7] External Investments and Daily Operations - Ningbo Huaxiang's subsidiary has been entrusted by Shanghai Zhiyuan to produce full-size biped robots [8] - Xinhongye's subsidiary won a bid for a 42.34 million yuan power cable procurement project from China Nuclear Construction [9] - Angel Yeast plans to invest 502 million yuan in the construction of a biological manufacturing center [10] - Hubei Yihua's phosphate chemical project has partially commenced full-load production [11] - Lian De Equipment is the first candidate for the bid for BOE's 8.6-generation AMOLED production line project, with a bid price of 157 million yuan [11] - China Foreign Transport's subsidiary plans to sell 25% equity of Lu Kai International for 3.382 billion yuan, expecting an investment return of 1.793 billion yuan [12] - Sitake plans to invest 12 million yuan in Huarui Xincai to enter the semiconductor photoresist field [13] - Jingce Electronics' subsidiary signed a sales contract for semiconductor testing equipment worth 113 million yuan [14] - Rijiu Optoelectronics' wholly-owned subsidiary Zhejiang Rijiu plans to invest approximately 822 million yuan to construct a functional film project with an annual output of 6 million square meters [14] Performance Changes - Dalian Heavy Industry expects a net profit of 305 million to 326 million yuan for the first half of the year, representing a year-on-year increase of 11.12% to 18.92%, mainly benefiting from the growth in gross profit of material handling equipment [15]

Group 1 - The company Haishun New Materials (300501.SZ) announced its intention to acquire 100% equity of Guangdong Zhengyi Packaging Co., Ltd. from Zeng Zewen, Zeng Minyin, and Fengyuan Technology for a preliminary transaction price of 94.87 million yuan [1] - Guangdong Zhengyi Packaging was successfully listed on the New Third Board in September 2020, with the stock code 873479 [1] - The main business of Zhengyi Packaging involves the research, production, and sales of packaging films, serving domestic printing and bag-making manufacturers, as well as food production companies [1]

海顺新材（300501）公告，公司正在筹划通过支付现金收购曾泽文、曾敏茵、丰远科技合计持有的广东 正一包装股份有限公司100%股权并取得正一包装的控股权。2025年6月25日，公司与正一包装股东及标 的公司签署了《股权收购意向协议》。根据协议，初步交易价格为9487万元。交易完成后，正一包装将 成为海顺新材的全资子公司。正一包装2024年末总资产为8063.03万元、净资产为4684.3万元，2024年度 收入为1.13亿元、净利润为1012.82万元。 ...

| 证券代码：300501 | 证券简称：海顺新材 | 公告编号：2025-058 | | --- | --- | --- | | 债券代码：123183 | 债券简称：海顺转债 | | 上海海顺新型药用包装材料股份有限公司 关于签署股权收购意向协议的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示： 1、上海海顺新型药用包装材料股份有限公司（以下简称"海顺新 材""公司""本公司"）正在筹划通过支付现金收购曾泽文、曾敏 茵、佛山市丰远科技中心（有限合伙）（以下简称"丰远科技"）合计 持有的广东正一包装股份有限公司（以下简称"正一包装"或"标的公 司"）100%股权并取得正一包装的控股权事项。 2025年6月25日，公司与正一包装股东曾泽文、曾敏茵、丰远科 技及标的公司签署了《股权收购意向协议》。 2、本次签订的《股权收购意向协议》仅属于各方合作意愿的框 架性、意向性约定，《股权收购意向协议》付诸实施和实施过程中均 存在变动的可能性。最终交易方案由交易各方进一步协商确定，并以 各方签署的正式协议为准。敬请广大投资者理性投资，谨慎决策，注 意投资风 ...

| 证券代码：300501 | 证券简称：海顺新材 | 公告编号：2025-057 | | --- | --- | --- | | 债券代码：123183 | 债券简称：海顺转债 | | 上海海顺新型药用包装材料股份有限公司 关于"海顺转债"恢复转股的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚假 记载、误导性陈述或重大遗漏。 特别提示： 1、债券代码：123183 债券简称：海顺转债 2、暂停转股时间：2025 年 6 月 13 日至 2025 年 6 月 20 日 3、恢复转股时间：2025 年 6 月 23 日 上海海顺新型药用包装材料股份有限公司（以下简称"公司"） 因实施 2024 年年度权益分派，根据《上海海顺新型药用包装材料股 份有限公司创业板向不特定对象发行可转换公司债券募集说明书》及 相关规定，公司可转换公司债券"海顺转债"于 2025 年 6 月 13 日至 2024 年年度权益分派股权登记日（2025 年 6 月 20 日）止暂停转股， 2024 年年度权益分派股权登记日后的第一个交易日起恢复转股。详 情请见公司于巨潮资讯网（www.cninfo.com.cn） ...

2023 年上海海顺新型药用包装材 料股份有限公司创业板向不特定 对象发行可转换公司债券2025年 跟踪评级报告 中鹏信评【2025】跟踪第【192】号 01 信用评级报告声明 除因本次评级事项本评级机构与评级对象构成委托关系外，本评级机构及评级从业人员与评级对象不存 在任何足以影响评级行为独立、客观、公正的关联关系。 本评级机构与评级从业人员已履行尽职调查义务，有充分理由保证所出具的评级报告遵循了真实、客观、 公正原则，但不对评级对象及其相关方提供或已正式对外公布信息的合法性、真实性、准确性和完整性 作任何保证。 本评级机构依据内部信用评级标准和工作程序对评级结果作出独立判断，不受任何组织或个人的影响。 本评级报告观点仅为本评级机构对评级对象信用状况的个体意见，不作为购买、出售、持有任何证券的 建议。本评级机构不对任何机构或个人因使用本评级报告及评级结果而导致的任何损失负责。 本次评级结果自本评级报告所注明日期起生效，有效期为被评证券的存续期。同时，本评级机构已对受 评对象的跟踪评级事项做出了明确安排，并有权在被评证券存续期间变更信用评级。本评级机构提醒报 告使用者应及时登陆本公司网站关注被评证券信用评级的 ...

股票简称：海顺新材 股票代码：300501.SZ 债券简称：海顺转债 债券代码：123183.SZ 上海海顺新型药用包装材料股份有限公司 向不特定对象发行可转换公司债券 受托管理事务报告 （2024 年度） 债券受托管理人 中信证券股份有限公司 （广东省深圳市福田区中心三路 8 号卓越时代广场（二期）北座） 二〇二五年六月 1 重要声明 中信证券股份有限公司（以下简称"中信证券"）编制本报告的内容及信息 均来源于上海海顺新型药用包装材料股份有限公司（以下简称"海顺新材"、"公 司"、"发行人"）对外公告的《上海海顺新型药用包装材料股份有限公司 2024 年年度报告》等相关公开信息披露文件、公司提供的证明文件以及第三方中介机 构出具的专业意见。 本报告不构成对投资者进行或不进行某项行为的推荐意见，投资者应对相关 事宜做出独立判断，而不应将本报告中的任何内容据以作为中信证券所作的承诺 或声明。 2 | 重要声明 2 | | | --- | --- | | 第一节 | 本次债券情况 4 | | 一、注册文件及发行规模 4 | | | 二、本期债券的主要条款 4 | | | 第二节 | 债券受托管理人履职情况 14 ...